Large-scale testing (Phase 3)Active Not RecruitingNCT06067230
What this trial is testing
Investigate the Immunogenicity and Safety of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in High-risk Adults
Who this might be right for
Respiratory Syncytial Virus
ModernaTX, Inc. 1,153